Search

everythinglearnresearchcommunity

for

Search:↓

People with hair loss are more likely to have anxiety.

Women with PCOS often face anxiety, depression, and low body appreciation, especially if they have alopecia, obesity, or a history of mental health issues.

Hair transplantation improves self-esteem and social confidence, but managing expectations and psychological risks is crucial for success.

Hair loss can affect mood, self-esteem, body image, and quality of life.

Ritlecitinib and baricitinib are similarly effective for hair regrowth in severe alopecia areata.

Baricitinib is effective and safe for long-term use in severe alopecia areata, improving hair regrowth and quality of life with few side effects.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Listening to music can help reduce anxiety before hair transplant surgery.

Treating skin conditions with both psychological and dermatological care improves patient outcomes and can save costs.

The FAW-FS algorithm improves depression recognition, and psychological interventions help AGA patients' mental health.

Androgenetic alopecia negatively affects emotions and self-confidence, especially in younger people.

Alopecia areata greatly affects people's life quality, mental health, and work life.

Telemedicine is effective for managing alopecia areata follow-ups.

Low dose finasteride decreases certain steroids, possibly increasing depression risk.

Depression and skin autoimmune diseases are linked, needing combined care for better treatment.

New-onset fibromyalgia after COVID-19 is poorly understood and needs more research.

Hair specialists vary in testing for alopecia areata, highlighting the need for standard guidelines.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Isotretinoin treatment in Palestine shows poor adherence to guidelines, with common side effects and a need for better prescribing practices and patient education.

Women with PCOS are more likely to have depression and anxiety.

JAK inhibitors effectively treat skin conditions and topical forms are safer.

Androgenetic alopecia causes significant psychological distress, especially in women, and requires both medical and psychological support.

Gut flora changes could potentially indicate depression, but more research is needed.

5α-reductase inhibitors can cause serious and possibly lasting sexual and psychological side effects.

Addressing alexithymia can improve anxiety and depression in alopecia areata patients.

Collaboration and innovation are key to developing effective, safe hair loss treatments.

Baricitinib effectively reduces hair loss in severe alopecia areata with mild side effects.

Adults and adolescents with severe alopecia areata are willing to take significant health risks for a better chance of hair regrowth.

New treatments for alopecia areata show promise, but standardized guidelines are needed.

Different treatments are effective for hair loss conditions, but results vary by individual factors.